Differentiation therapy in glioma – screening for modulators of differentiation commitment

descriptionPublicationkeyboard_double_arrow_right Conference object 09 Jun 2017 English Publisher:German Medical Science GMS Publishing House; Düsseldorf

Authors: Bulstrode, H; Pollard, S;

doi: 10.3205/17dgnc174

Differentiation therapy in glioma – screening for modulators of differentiation commitment

- Summary
- Subjects
- Metrics

Abstract

Objectives: It is now clear that neural stem cell identity in a subset of tumour cells is key to malignancy in high grade glioma, and probably also in lower grade lesions. Inducing stable therapeutic differentiation commitment in the glioma NS cells which persist after surgical resection offers the [for full text, please go to the a.m. URL]

68. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC), 7. Joint Meeting mit der Society of British Neurological Surgeons (SBNS)

Related Organizations

University of Edinburgh
United Kingdom
MRC Centre for Regenerative Medicine
United Kingdom
Medical Research Council
United Kingdom
University of Cambridge
United Kingdom

Keywords

ddc: 610, 610 Medical sciences; Medicine

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	0
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Average
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Average
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Average